Growth Metrics

Rapid Micro Biosystems (RPID) FCF Margin Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 38.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 30.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 943.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 96.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -2,196.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -20.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2,679.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -461.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 417.00
10 Rapid Micro Biosystems 89.50 Mn 66.56 Mn 371,000.00 14,136.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 14,136.00
Dec 31, 2025 39,071.00
Sep 30, 2025 10,316.00
Jun 30, 2025 30,955.00
Mar 31, 2025 33,019.00
Dec 31, 2024 16,120.00
Sep 30, 2024 18,680.00
Jun 30, 2024 3,669.00
Mar 31, 2024 -5,662.00
Dec 31, 2023 -5,268.00
Sep 30, 2023 -452.00